|
|
|
|
LEADER |
01850nam a22003735i 4500 |
001 |
000281796 |
005 |
20211029085001.0 |
007 |
cr nn 008mamaa |
008 |
100301s2008 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781597452106
|
024 |
7 |
|
|a 10.1007/978-1-59745-210-6
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Drug Delivery Systems /
|c edited by Kewal K. Jain.
|
250 |
|
|
|a 1st ed. 2008.
|
260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2008.
|
300 |
|
|
|a X, 251 p. 55 illus. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Methods in Molecular Biology,
|v 437
|
505 |
0 |
|
|a Drug Delivery Systems - An Overview -- The Role of the Adeno-Associated Virus Capsid in Gene Transfer -- Delivering Small Interfering RNA for Novel Therapeutics -- Catheters for Chronic Administration of Drugs into Brain Tissue -- Transdermal Drug Delivery Systems: Skin Perturbation Devices -- Controlling the Release of Proteins/Peptides via the Pulmonary Route -- Engineering Protein Particles for Pulmonary Drug Delivery -- 2B-Trans™ Technology: Targeted Drug Delivery Across the Blood-Brain Barrier -- Drug Delivery in Cancer Using Liposomes -- pH-Responsive Nanoparticles for Cancer Drug Delivery -- Extended-Release Oral Drug Delivery Technologies: Monolithic Matrix Systems.
|
650 |
|
0 |
|a Biotechnology.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Molecular biology.
|
650 |
|
0 |
|a Biochemistry.
|
650 |
|
0 |
|a Immunology.
|
650 |
1 |
4 |
|a Biotechnology.
|
650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Molecular Medicine.
|
650 |
2 |
4 |
|a Biochemistry, general.
|
650 |
2 |
4 |
|a Immunology.
|
700 |
1 |
|
|a Jain, Kewal K.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|